Michalle Adkins

Director, Life Sciences Strategy • Emerson

Michalle Adkins, Director Life Sciences Strategy, has been with Emerson for 18 years.  She is responsible for developing the future vision and cohesive strategy across the Emerson Life Sciences digital portfolio.  In her previous role, she led the Life Sciences Consulting team where they used their varied experiences to work with several top pharmaceutical and biotech companies to provide consulting services for digital plant maturity current state assessments, future state planning, solutions mapping, business justifications, and project definition.  Prior to Emerson, she worked for Merck & Co., Inc for 13 years in instrumentation, automation, manufacturing automation support, computer validation, manufacturing, and scheduling and planning.

Ms. Adkins has a B.S. in Chemical Engineering and an M.E. in Industrial Engineering from The Pennsylvania State University as well as a Six Sigma Black Belt Master’s Certificate from Villanova University.  She has been a speaker at several conferences including IFPAC, ISPE, Interphex, PMWS, CBI MES, and Emerson Exchange.  She has published articles in several magazines including Life Science Leader, BioProcess Int’l, Chemical Engineering, and Chemical Engineering Progress.

Also Speaking

Jordan Fabry

Product Specialist – Clarification Studies, Separations Technologies North America • Sartorius Stedim Biotech

Nina Bauer

Global Head of Commercial, Biologics and Viral Vector CTDMO • MilliporeSigma

Carl H. June

Director of the Center for Cellular Immunotherapies at the Perelman School of Medicine • University of Pennsylvania

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2024.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.